Cabozantinib, nuevo estándar de tratamiento del Carcinoma Hepatocelular

Cover

Previous Page

9 / 30

Next Page

Information

Previous Page

9 / 30

Next Page

Page Background

Cabozantinib Phase II study

Kelley RK., et al. Annals of Oncology 2017;28: 528–534.

1 … 4 5 6 7 8 9 10 11 12 13 14 15 … 30